Breast Cancer Treatment in Istanbul: Why Choose Turkey?

MedTravelExpertise — Vaš pouzdani zdravstveni partner

Dobijte besplatnu personalizovanu ponudu danas

Razgovarajte sa posvećenim koordinatorom — besplatna konsultacija, bez obaveze, višejezična podrška 7 dana u nedelji.

💬 Pišite nam na WhatsApp za besplatnu ponudu

Istanbul has emerged as a leading destination for breast cancer treatment, combining JCI-accredited oncology centers with costs 60-75% lower than the Srbiji, Germany, or USA. Multidisciplinary tumor boards, advanced molecular diagnostics, and English-speaking oncologists make Istanbul a viable option for international patients.

📋

Free Treatment Guide PDF

Costs, clinics, recovery timelines and what to ask your surgeon.

How much does breast cancer treatment cost in Istanbul?

A full breast cancer treatment course in Istanbul costs $8,000–$25,000 depending on cancer stage and treatment protocol. This compares to €X.XXX–€XX.XXX in the Srbiji and $50,000–$150,000 in the USA. The cost difference reflects Turkey's lower operational costs, not lower quality standards.

Save Up to 70% Compared to Western Prices

See How Much You Could Save

Compare our JCI-accredited partner hospital rates against your home country pricing — completely free of charge.

💬 Compare My Savings on WhatsApp

What breast cancer treatments are available?

Istanbul's oncology centers offer the complete treatment spectrum: breast-conserving surgery (lumpectomy), mastectomy with reconstruction, sentinel lymph node biopsy, chemotherapy, targeted therapy (Herceptin, CDK4/6 inhibitors, PARP inhibitors), hormone therapy, and radiotherapy.

JCI-Accredited Breast Cancer Centers in Istanbul

Acibadem, Memorial, Medipol, and Florence Nightingale hospitals hold JCI accreditation and have dedicated breast oncology units with tumor boards that meet weekly to review complex cases. All follow ESMO and NCCN treatment guidelines.

HER2-Positive and Triple-Negative Breast Cancer

Istanbul centers offer targeted therapy for HER2-positive breast cancer including trastuzumab, pertuzumab, and T-DM1 at 50-60% lower cost than the Srbiji. For triple-negative breast cancer, immunotherapy with pembrolizumab is available at select centers.

MedTravelExpertise — JCI-Accredited Hospital Network

Ready to Take the Next Step?

Our multilingual team is available 7 days a week. No obligation, just expert guidance tailored to your needs.

💬 Start Your Free Consultation on WhatsApp